{"name":"Neurona Therapeutics","slug":"neurona-therapeutics","ticker":"","exchange":"","domain":"neurona.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQNVQyZUFuNVQxV1VrbFZLRlllZkI5bjdfQzU5bjJGSk05M21OZW55Zk1pX29JUjAtWlBzQzhZX1VrVEJwYlN0QXBDWk8wT2o5YXI3ZHZTbDd0Slg2YXhXbmk0WjctVmlmdzRYY1lfZEJjVlZyamVKUlh0cnNMbDZwblFOdDAyWmltX3pzcDhXckZsRU85QTdIQWRpNVRzSjlzN0dWM1dGQ3lWUQ?oc=5","date":"2026-03-09","type":"trial","source":"seekingalpha.com","summary":"Xenon: Shares Soar On Seizure Data, But Valuation May Be Overcooked (NASDAQ:XENE) - seekingalpha.com","headline":"Xenon: Shares Soar On Seizure Data, But Valuation May Be Overcooked (NASDAQ:XENE)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgJBVV95cUxPTjE1YUV5X2czdnZ2cDlEZjZXd0RLenQ1RzcxNzF0Y3liWXBGQlNVbURMUklDNFc2RFpjaF9PQXkyYjFtQUxJS3FXbUszcDhQZkdDczZPUXNYbEFoOGlHV05SV1B0NzFaWmlqTE00d01ZQVAtRFRDT1pYeG1NZVdQRjItSUplWUZPaWZmZ3RyVUVFaUVfNzY2bVRiYjVRV3llb3JQVzEtNjl0SEVtMVpVWDZxYmNTdlVXU2J0bmFCa3pWLXJpU3oxdmxPem1ObmNEblE3bXlCck5fejZBMk84X2RjaXhhZEhHRDg5NHY2bWVOMGttSDRad2k3UTZPaEk5Z0IyMGV4ZlA3OWZIWEliQlpPOTFNZw?oc=5","date":"2026-02-24","type":"regulatory","source":"PR Newswire","summary":"Drug-Resistant Epilepsy Market to Accelerate With Significant CAGR by 2036 as Demand for Advanced Therapies Increases | DelveInsight - PR Newswire","headline":"Drug-Resistant Epilepsy Market to Accelerate With Significant CAGR by 2036 as Demand for Advanced Therapies Increases | ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE80NGNTbTZtSFRQdi1YVkNhQVhWVk9DWUZPMzhSZzcxbG8weWRHRlVYZTJJeU1fNG9NRXcxenRVM243V2l0VnlzNGpLQVQ4TlJZVXpQWktKXzlZWGc1RTNj?oc=5","date":"2026-01-16","type":"pipeline","source":"Nature","summary":"People - Nature","headline":"People","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNMmxsZ01ObmFmeHVUN19nRjFieGI3SGY5b285ZGcyTEVUd0ZVT1Zubl9FREpRRGtDLUtRQjNKODZkZmZYcUFCZVpxUUlZamZqMjA0dlRGdEh1ZFByX1lodmJiRE9VQ1NJMTBBWWNYUDAtZHMwMUlZWHEwTkthWkpxRzR0MlhXZE9DTi1uOEFqeEkyaElLUmViVjlyYw?oc=5","date":"2025-11-21","type":"pipeline","source":"Fierce Biotech","summary":"Gilead abruptly parts ways with general counsel—Chutes & Ladders - Fierce Biotech","headline":"Gilead abruptly parts ways with general counsel—Chutes & Ladders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPMW1jb1NCSnFLRVVINXFianoxbTd6Y1lFQ2RNNHJZVzYxb2JUczRzajdPc2d0RVQ2eDlZWENZZ1VSZkZBRUlJSGdKblFNU3ctbkV1MkI0aVdETFctUTZ6TVg0UldXaHVnWGxXcVlkaWdPNnIwa0VXRWN4cVJLYWstOXloQXIyaDNQcDAwYnRNQjVvN3AxaVdBaEt4MEhhT0MzQmc?oc=5","date":"2025-08-25","type":"pipeline","source":"NYU Langone Health","summary":"Most Epilepsy Patients Wait a Year After Starting Treatment for Seizure Relief - NYU Langone Health","headline":"Most Epilepsy Patients Wait a Year After Starting Treatment for Seizure Relief","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOSk9fSzZOeVAydV9fXzVPdHBJZG5jUjRfN0pNT3JtMXFrZFh1RVhJekJYSzBSdlBZNVBrQWJ0SkhMaWNjMjBJa3JsTFJnSkpocGFzNWlTb09BWWR6NE5RX1pQV1NTUXVsLTJmZU1Rcl9aM05MRVBpOVhZWGRBY3VkRjMzeHBSRS1nSm00a1k1ZVFhdUZ4Rm9aYnFOTGdsek1iU0p5WDNEd090WENRM252Ny1XNlRYdFB3YXY0?oc=5","date":"2025-04-03","type":"pipeline","source":"Pharmaceutical Technology","summary":"Neurona raises $102m to advance cell therapy for drug-resistant epilepsy - Pharmaceutical Technology","headline":"Neurona raises $102m to advance cell therapy for drug-resistant epilepsy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9kXzdLWVNUbUZPWWZhZGNGYnUwSllCSW1Edk9tcVlvcV8wUVY5QlpNN2xYX18ydFNTSUVseUg5cFJUTHVUZkgtUGVyMDh2YkloU193?oc=5","date":"2025-04-03","type":"trial","source":"FirstWord Pharma","summary":"Neurona nabs $102M to launch pivotal trial of epilepsy cell therapy - FirstWord Pharma","headline":"Neurona nabs $102M to launch pivotal trial of epilepsy cell therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAJBVV95cUxPWm5YLU1NWU5pTEV6cHY5Zm0tRmVDM1UtdFNoSjFUUHRGWTZkRU1rdFlRaGhiTWxLR011b0tmMUNMMkUzUHNMdUtNcjluNkFnbVlNT0hmX01vVzdCMFdfZEFOS3RmY3U4MFpVMVZNYUh0R012LU9VUWhRTko3SHBCR1ZZVWs3M2kycnI5bEw2djVfd2dabWh4ajdoUlhzVWp1SklGaEZ4SXpyUWpsYkFITFNhTVdidjZsVkxKMEE3a2RJT0U4MnBmeTY4Um1NcS1ZZmpBNzNZRGt2bHVzN1ZPR1pYUUVBYm11blh3aVZxS3BWZllPYy1tRFdjRGxobXhjUmxvODA2Y0VuNmtxbUFtS2lyamFUTGtaU0N6aTIwbFhDUU9laGZNWGJmQWk?oc=5","date":"2025-04-03","type":"pipeline","source":"GlobeNewswire","summary":"Neurona Therapeutics Raises $102 Million to Fuel NRTX-1001 - GlobeNewswire","headline":"Neurona Therapeutics Raises $102 Million to Fuel NRTX-1001","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE5lMGp2c01DMXM2dmdjVWNXYjRmNUV1U1VMdlNhUW1vdUhyZDdqOERKeVl4aHdZZ3ExS2dWMmJhVWdwODRxel9OR3V4WFBZRTROa0ZaNG1tV1NaYXRCTW82akY0anRMOFZXaF9wV29Lc1lCWUJo?oc=5","date":"2024-07-14","type":"pipeline","source":"The Pharma Letter","summary":"Neurona Therapeutics - The Pharma Letter","headline":"Neurona Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQcmJRZ1h3UjV2TFl0cVRVbWd3V1p1Q3pUek1pNTNENHNobndXVFQ5UnpQS1lXU3dVa3RSeC13bGkyWnFvQ0YyMkx6OEpJMExLVmREa0xyYUU3YzU4aWhOa3QydjN0dlBSUmg1aEgzNW02NkpCNjEzcVprbHhaemxKNjNBNDNLS0pmbEJLVmxaRWtVdEJ2SGdVZ1ZpR3QzaHZWT2ZXbQ?oc=5","date":"2024-02-16","type":"pipeline","source":"PharmaTimes","summary":"Neurona secures $120m to advance lead cell therapy candidate for epilepsy - PharmaTimes","headline":"Neurona secures $120m to advance lead cell therapy candidate for epilepsy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPQ3FpSXdUNDc2Z01Gd0c1bzltd1JqNkVUc2s1LTNPV0JiNGRDNXVDVU1xMV9iaUJ4SWVkeV9TazhvY1pHR1daazJqN3RldFpnYnA0Tks4MXFYV3BreTQ0Y2sxLUFrbFRwOUZQVHBpY3BBb0ZOTTlCZzI0Z0N6SS1tU3N5VkxKT3lYRGNwd2l5TVlnZnQx?oc=5","date":"2024-02-08","type":"pipeline","source":"BioPharma Dive","summary":"Neurona raises another $120M for brain disease cell therapies - BioPharma Dive","headline":"Neurona raises another $120M for brain disease cell therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQSmljZTZ1NWJxSUJMa0xkVGFJcnd6VXZxRHViVkdKZ2k0eGpUYkYtUDhnTWJTY3FmMmtNeUxkcmxSQjc0cXl4S0FaRGRRWkhyTm1ZYU1qZ3FmRUpWaXNySmpmV2NHazRaUTcyR2c2eEQ1NzNOUmIySFNaNjVIOU1kWkQxc3RXSVNoS3c?oc=5","date":"2023-06-15","type":"trial","source":"Clinical Trials Arena","summary":"Neurona’s brain stem cell therapy shows early efficacy in epilepsy - Clinical Trials Arena","headline":"Neurona’s brain stem cell therapy shows early efficacy in epilepsy","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}